TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease

TOB-STOP-COP (TOBacco STOP in COPd trial): study protocol—a randomized open-label, superiority, multicenter, two-arm intervention study of the effect of “high-intensity” vs. “low-intensity” smoking cessation intervention in active smokers with chronic obstructive pulmonary disease

Abstract Background Cigarette smoking is the leading cause of chronic obstructive pulmonary disease (COPD), and it contributes to the development of many other serious diseases. Smoking cessation in COPD patients is known to improve survival and reduce the number of hospitalization-requiring acute e...

Full description

Bibliographic Details
Main Authors: Mohamad Isam Saeed, Pradeesh Sivapalan, Josefin Eklöf, Charlotte Suppli Ulrik, Charlotta Pisinger, Therese Lapperre, Philip Tønnesen, Nils Hoyer, Julie Janner, Marie Lavesen Karlsson, Charlotte Sandau Bech, Kristoffer Marså, Nina Godtfredsen, Eva Brøndum, Birgit Munk, Merete Raaschou, Andrea Browatzski, Pernille Lütken, Jens-Ulrik Stæhr Jensen
Format: Article
Language:English
Published: BMC 2020-08-01
Series:Trials
Subjects:
COPD
Randomized controlled trial
Smoking cessation
Exacerbations
Varenicline
Online Access:http://link.springer.com/article/10.1186/s13063-020-04653-z

Internet

http://link.springer.com/article/10.1186/s13063-020-04653-z

Similar Items